SEOM clinical guideline in ovarian cancer (2020)

被引：0

作者：

A. Redondo

E. Guerra

L. Manso

C. Martin-Lorente

J. Martinez-Garcia

J. A. Perez-Fidalgo

M. Q. Varela

M. J. Rubio

M. P. Barretina-Ginesta

A. Gonzalez-Martin

机构：

[1] Hospital Universitario La Paz-IdiPAZ,Girona Biomedical Research Institute (IdIBGi) and Department of Medical Sciences

[2] Universidad Autónoma de Madrid (UAM),undefined

[3] Hospital Universitario Ramón y Cajal,undefined

[4] Hospital Universitario 12 de Octubre-i+12,undefined

[5] Hospital de la Santa Creu i Sant Pau,undefined

[6] Hospital Clínico Universitario Virgen de la Arrixaca,undefined

[7] Hospital Clínico Universitario,undefined

[8] Biomedical Research Institute INCLIVA,undefined

[9] University of Valencia,undefined

[10] Complexo Hospitalario Universitario de A Coruña,undefined

[11] Hospital Universitario Reina Sofía,undefined

[12] Universidad de Córdoba (UCO),undefined

[13] Instituto Catalán de Oncología (ICO),undefined

[14] Medical School University of Girona,undefined

[15] Clínica Universidad de Navarra,undefined

来源：

Clinical and Translational Oncology | 2021年 / 23卷

关键词：

Ovarian cancer; Guideline; Diagnosis; Treatment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer remains the leading cause of death from gynecologic cancer. In the last decade, there have been important advances both in systemic and surgical treatment. However, there is no doubt that the incorporation of PARP inhibitors as maintenance after the response to platinum-based chemotherapy, first in recurrent disease and recently also in first line, will change the natural history of the disease.

引用

页码：961 / 968

页数：7

共 50 条

[21] SEOM clinical guideline on hereditary colorectal cancer (2019)
C. Guillén-Ponce
E. Lastra
I. Lorenzo-Lorenzo
T. Martín Gómez
R. Morales Chamorro
A. B. Sánchez-Heras
R. Serrano
M. C. Soriano Rodríguez
J. L. Soto
L. Robles
Clinical and Translational Oncology, 2020, 22 : 201 - 212
[22] SEOM clinical guideline for treatment of kidney cancer (2019)
Lazaro, M.
Valderrama, B. P.
Suarez, C.
de-Velasco, G.
Beato, C.
Chirivella, I.
Gonzalez-del-Alba, A.
Lainez, N.
Mendez-Vidal, M. J.
Arranz, J. A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 256 - 269
[23] SEOM clinical guideline on unknown primary cancer (2017)
F. Losa
G. Soler
A. Casado
A. Estival
I. Fernández
S. Giménez
F. Longo
R. Pazo-Cid
J. Salgado
M. Á. Seguí
Clinical and Translational Oncology, 2018, 20 : 89 - 96
[24] SEOM Clinical Guideline of localized rectal cancer (2016)
E. González-Flores
F. Losa
C. Pericay
E. Polo
S. Roselló
M. J. Safont
R. Vera
J. Aparicio
M. T. Cano
C. Fernández-Martos
Clinical and Translational Oncology, 2016, 18 : 1163 - 1171
[25] SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
Vera, R.
Dotor, E.
Feliu, J.
Gonzalez, E.
Laquente, B.
Macarulla, T.
Martinez, E.
Maurel, J.
Salgado, M.
Manzano, J. L.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12): : 1172 - 1178
[26] SEOM clinical guideline for treatment of kidney cancer (2017)
E. Gallardo
M. J. Méndez-Vidal
J. L. Pérez-Gracia
J. M. Sepúlveda-Sánchez
M. Campayo
I. Chirivella-González
X. García-del-Muro
A. González-del-Alba
E. Grande
C. Suárez
Clinical and Translational Oncology, 2018, 20 : 47 - 56
[27] SEOM clinical guideline for treatment of cancer pain (2017)
C. Jara
S. del Barco
C. Grávalos
S. Hoyos
B. Hernández
M. Muñoz
T. Quintanar
J. A. Meana
C. Rodriguez
R. de las Peñas
Clinical and Translational Oncology, 2018, 20 : 97 - 107
[28] SEOM clinical guideline on unknown primary cancer (2017)
Losa, F.
Soler, G.
Casado, A.
Estival, A.
Fernandez, I.
Gimenez, S.
Longo, F.
Pazo-Cid, R.
Salgado, J.
Segui, M. A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 89 - 96
[29] Clinical guideline SEOM: cancer of unknown primary site
R. Collado Martín
A. García Palomo
L. de la Cruz Merino
P. Borrega García
F. J. Barón Duarte
Clinical and Translational Oncology, 2014, 16 : 1091 - 1097
[30] SEOM clinical guideline for treatment of kidney cancer (2019)
M. Lázaro
B. P. Valderrama
C. Suárez
G. de-Velasco
C. Beato
I. Chirivella
A. González-del-Alba
N. Laínez
M. J. Méndez-Vidal
J. A. Arranz
Clinical and Translational Oncology, 2020, 22 : 256 - 269

← 1 2 3 4 5 →